Efficacy of Myo-Inositol in the Treatment of Cutaneous Disorders in Young Women with Polycystic Ovary Syndrome

January 2009 in “ Gynecological Endocrinology ”

Martino Zacchè, Luigi Caputo, S. Filippis, G Zacchè, M Dindelli, Augusto Ferrari

TLDR Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

In a study conducted from May 2007 to August 2008 involving 50 young women with polycystic ovary syndrome (PCOS), researchers evaluated the efficacy of myo-inositol (MYO) in treating cutaneous disorders like hirsutism and acne. Participants, averaging 25.4 years of age, received 2 grams of MYO and 200 micrograms of folic acid twice daily for 6 months. The treatment led to significant reductions in plasma luteinizing hormone, testosterone, free testosterone, insulin levels, and the homeostasis model assessment index after 3 months, with no significant changes in follicle-stimulating hormone and androstenedione levels. After 6 months, clinical improvements in hirsutism and acne were observed. The study concluded that MYO is a simple and safe treatment that improves the metabolic profile of PCOS patients and reduces hirsutism and acne.

View this study on tandfonline.com →

Discuss this study in the Community →

Cited in this study

5 / 5 results

research Hair Loss in Women

129 citations , October 2007 in “The New England Journal of Medicine”

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

research Dermatology of Androgen-Related Disorders

67 citations , July 2006 in “Clinics in Dermatology”

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations , January 2004 in “Human Reproduction”

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

research Polycystic Ovary Syndrome and Insulin-Resistant Hyperinsulinemia

60 citations , September 2001 in “Journal of the American Academy of Dermatology”

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

research Polycystic Ovary Syndrome: Clinical and Biochemical Features

1947 citations , September 1995 in “New England journal of medicine/The New England journal of medicine”

PCOS is a common hormonal disorder causing irregular periods and increased hair growth, linked to insulin resistance and long-term health issues.

1 / 1 results

research Efficacy of Myo-Inositol in the Treatment of Cutaneous Disorders in Young Women with Polycystic Ovary Syndrome

64 citations , January 2009 in “Gynecological Endocrinology”

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.